Email this article 
CASE REPORT : LOW LEVEL IMMUNOGLOBULING (IGG) IN REINFECTION COVID-19 CASE
Abstract
Million people have infected the SARS-CoV-2 epidemic, which is currently spreading. We describe a confirmed COVID-19 patient whose oropharyngeal swab test for SARS-CoV-2 RNA and have positive PCR test results after 8 weeks proclaim negative result of PCR test for SARS-COV-2. ImmunoglobulinG was not detected during the initial illness. In this study, we discuss the potential role of low IgG in cases of reinfection.
Keywords
Full Text:
PDFReferences
Vijairam Selvaraj MKH, MD; Kwame Dapaah-Afriye,MD. Severe, Symptomatic Reinfection in patient with COVID-19. RHODE ISLAND MEDICAL JOURNAL. 2020/08/26 ed2020.
WHO. Coronavirus disease (COVID-19) technical guidance : Laboratory testing for 2019-nCoV in humans. World Health Organization; 2020.
Tao W, Wang X, Zhang G, Guo M, Ma H, Zhao D, et al. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein Cell. 2020.
Noh JY, Yoon JG, Seong H, Choi WS, Sohn JW, Cheong HJ, et al. Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration. Journal of Infection. 2020;81(5):816-46.
Duggan NM, Ludy SM, Shannon BC, Reisner AT, Wilcox SR. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results. Am J Emerg Med. 2021;39:256 e1- e3.
Wang Y, Guo Q, Yan Z, Zhou D, Zhang W, Zhou S, et al. Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection. J Infect Dis. 2018;217(11):1708-17.
Xiao AT, Tong YX, Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J Med Virol. 2020;92(10):1755-6.
ECDC. Reinfection with SARS-CoV-2: Considerations for public health response. European Centre for Disease Prevention and Control. 2020.
Liu B, Shi Y, Zhang W, Li R, He Z, Yang X, et al. Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies. Cell Mol Immunol. 2020;17(10):1098-100.
Chaturvedi R, Naidu R, Sheth S, Chakravarthy K. Efficacy of Serology Testing in Predicting Reinfection in Patients With SARS-CoV-2. Disaster Med Public Health Prep. 2020:1-3.
Bentivegna E, Sentimentale A, Luciani M, Speranza ML, Guerritore L, Martelletti P. New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient. J Med Virol. 2020.
Elrashdy F, Aljaddawi AA, Redwan EM, Uversky VN. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity. J Biomol Struct Dyn. 2020:1-12.
Choe PG, Kang CK, Suh HJ, Jung J, Kang E, Lee SY, et al. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients. Emerg Infect Dis. 2020;26(10):2484-7.
DOI: https://doi.org/10.32539/JKK.V9I3.18828
Refbacks
- There are currently no refbacks.
E-ISSN (Online) : 2614-0411
Jl. Dr. Moehammad Ali Kompleks RSMH Palembang 30126, Indonesia
Telp. 0711-352342, Fax.: 0711-373438
email: jurnalfkunsri@gmail.com
Jurnal Kedokteran dan Kesehatan : Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya by https://ejournal.unsri.ac.id/index.php/jkk is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.